BRC News

UCL researchers have found for the first time a double mutation in frontotemporal dementia (FTD), which may further our understanding of the underlying processes involved in these diseases.

BRC Director Professor Bryan Williams attended 10 Downing Street today for the official launch of Genomics England (GEL). 

Researchers have discovered genetic mutations which cause a decrease in dopamine production in the brain and lead to a form of childhood-onset Dystonia, also play a role in the development of Parkinson’s disease.  

Hundreds of visitors turned out for a special exhibition of research this month at UCLH.

Results of a worldwide study could help revolutionise how Parkinson's disease is treated, according to research published this week. Image courtesy of Wellcome Images

Cutting alcohol consumption, even for light-to-moderate drinkers, could be linked to improved cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index and blood pressure, according to research published this week.

The first patient has been dosed at the Leonard Wolfson Experimental Neurology Centre Clinical Facility in a trial to test whether a diabetes drug may have real promise in helping to slow down Parkinson's disease. Image courtesy of Wellcome Images

UCLH consultants are studying the effects of inpatients using portable electronic devices to report and self-manage pain after surgery.

University College London Hospitals NHS Foundation Trust is putting the spotlight on research today.

A blood test could offer many women an early warning of breast cancer even if they do not inherit the high-risk BRCA1 gene mutation, according findings published today. Image courtesy of Wellcome Images

UCLH is putting the spotlight on research and inviting the public to come and find out how clinical research at the trust is changing patient care.

University College London Hospitals NHS Foundation Trust (UCLH) is one of the top trusts in providing opportunities for patients to take part in clinical research studies.

The BRC is inviting applications for funding for Infection, Immunity and Inflammation (III) research.

The immune system and body’s response to damaged cells play a key role in the development of frontotemporal dementia (FTD), according to the latest research by an international team of researchers.

UCL is to collaborate with Chiesi Group to test a novel therapeutic to protect babies suffering from birth asphyxia from brain damage.